NCT02870049

Brief Summary

The purpose of this study is to determine whether inreach and outreach strategies will be superior to usual care, and combination of both will be superior to either strategy alone.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
673

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable colorectal-cancer

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 17, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
6 years until next milestone

Results Posted

Study results publicly available

September 4, 2025

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

August 8, 2016

Results QC Date

April 10, 2024

Last Update Submit

August 30, 2025

Conditions

Keywords

early detection

Outcome Measures

Primary Outcomes (1)

  • Screening Completion Rate

    Completion of any colorectal cancer screening test (FIT, sigmoidoscopy or colonoscopy)

    23 months

Study Arms (4)

Inreach strategy

EXPERIMENTAL

This consists of a community health worker-delivered in clinic education regrading CRC screening with a fecal immunochemical test (FIT) kit, and telephone reminders.

Behavioral: Inreach strategy

Outreach strategy

EXPERIMENTAL

This consists of mailed invitations to complete screening with an enclosed fecal immunochemical test (FIT) kit and telephone reminders.

Behavioral: Outreach strategy

Both Inreach and Outreach strategies

EXPERIMENTAL

This is a combination of the above two strategies: Inreach and Outreach combined.

Behavioral: Both Inreach and Outreach strategies

Usual care

ACTIVE COMPARATOR

Usual care in the clinic using the fecal immunochemical test (FIT) kit.

Behavioral: Usual care

Interventions

Inreach strategy: In clinic education and delivery of fecal immunochemical test (FIT) kit

Inreach strategy

Outreach strategy: Mailed fecal immunochemical test (FIT) kit and telephone reminders

Outreach strategy

Both Inreach and Outreach strategies: Both In clinic education and delivery of fecal immunochemical test (FIT) kit and Mailed fecal immunochemical test (FIT) kit and telephone reminders

Both Inreach and Outreach strategies
Usual careBEHAVIORAL

Usual care: FIT kit delivery as part of usual care

Usual care

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals age 50 to 75 years,
  • One or more SYHC visits in the last year,
  • Not uptodate with CRC screening

You may not qualify if:

  • Individuals with personal history of CRC or colorectal polyps

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Results Point of Contact

Title
Samir Gupta, MD
Organization
UC San Diego

Study Officials

  • Samir Gupta, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Sheila Castaneda, PhD

    San Diego State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Clinical Medicine

Study Record Dates

First Submitted

August 8, 2016

First Posted

August 17, 2016

Study Start

August 1, 2016

Primary Completion

July 9, 2018

Study Completion

August 30, 2019

Last Updated

September 4, 2025

Results First Posted

September 4, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share